BIOC Annual EBIT
-$31.90 M
-$29.49 M-1224.03%
31 December 2022
Summary:
As of February 5, 2025, BIOC annual earnings before interest & taxes is -$31.90 million, with the most recent change of -$29.49 million (-1224.03%) on December 31, 2022. During the last 3 years, it has fallen by -$7.01 million (-28.16%). BIOC annual EBIT is now -1224.03% below its all-time high of -$879.00 thousand.BIOC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOC Quarterly EBIT
-$3.58 M
+$3.52 M+49.55%
30 June 2023
Summary:
As of February 5, 2025, BIOC quarterly earnings before interest & taxes is -$3.58 million, with the most recent change of +$3.52 million (+49.55%) on June 30, 2023. Over the past year, it has increased by +$6.31 million (+63.79%). BIOC quarterly EBIT is now -234.42% below its all-time high of $2.66 million, reached on March 31, 2021.BIOC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOC TTM EBIT
-$30.54 M
+$6.31 M+17.12%
30 June 2023
Summary:
As of February 5, 2025, BIOC TTM earnings before interest & taxes is -$30.54 million, with the most recent change of +$6.31 million (+17.12%) on June 30, 2023. Over the past year, it has dropped by -$15.17 million (-98.76%). BIOC TTM EBIT is now -1409.46% below its all-time high of $2.33 million, reached on September 30, 2021.BIOC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOC EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1224.0% | +63.8% | -98.8% |
| 3 y3 years | -28.2% | +44.3% | -17.5% |
| 5 y5 years | -50.6% | +41.0% | -22.7% |
BIOC EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1224.0% | at low | -66.6% | +64.5% | -1167.1% | +17.1% |
| 5 y | 5-year | -1224.0% | at low | -234.4% | +64.5% | -1409.5% | +17.1% |
| alltime | all time | -1224.0% | at low | -234.4% | +64.5% | -1409.5% | +17.1% |
Biocept EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$3.58 M(-49.5%) | -$30.54 M(-17.1%) |
| Mar 2023 | - | -$7.10 M(-27.5%) | -$36.85 M(+15.5%) |
| Dec 2022 | -$31.90 M(+1224.0%) | -$9.79 M(-2.8%) | -$31.90 M(+28.2%) |
| Sept 2022 | - | -$10.07 M(+1.9%) | -$24.89 M(+62.0%) |
| June 2022 | - | -$9.89 M(+360.2%) | -$15.36 M(+112.7%) |
| Mar 2022 | - | -$2.15 M(-22.6%) | -$7.22 M(+199.7%) |
| Dec 2021 | -$2.41 M(-86.3%) | -$2.78 M(+404.7%) | -$2.41 M(-203.3%) |
| Sept 2021 | - | -$550.00 K(-68.5%) | $2.33 M(-220.4%) |
| June 2021 | - | -$1.75 M(-165.6%) | -$1.94 M(-70.8%) |
| Mar 2021 | - | $2.66 M(+35.5%) | -$6.62 M(-62.3%) |
| Dec 2020 | -$17.57 M(-29.4%) | $1.97 M(-140.8%) | -$17.57 M(-30.2%) |
| Sept 2020 | - | -$4.82 M(-25.1%) | -$25.19 M(-3.1%) |
| June 2020 | - | -$6.43 M(-22.3%) | -$26.00 M(-4.8%) |
| Mar 2020 | - | -$8.28 M(+46.6%) | -$27.32 M(+9.8%) |
| Dec 2019 | -$24.89 M(+2.6%) | -$5.65 M(+0.4%) | -$24.89 M(-1.1%) |
| Sept 2019 | - | -$5.63 M(-27.4%) | -$25.17 M(-1.4%) |
| June 2019 | - | -$7.75 M(+32.4%) | -$25.52 M(+7.1%) |
| Mar 2019 | - | -$5.85 M(-1.3%) | -$23.84 M(-1.7%) |
| Dec 2018 | -$24.26 M(+14.6%) | -$5.93 M(-0.9%) | -$24.26 M(+1.3%) |
| Sept 2018 | - | -$5.98 M(-1.4%) | -$23.94 M(+1.1%) |
| June 2018 | - | -$6.07 M(-3.3%) | -$23.69 M(+2.6%) |
| Mar 2018 | - | -$6.27 M(+11.7%) | -$23.10 M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$21.17 M(+17.5%) | -$5.62 M(-2.0%) | -$21.17 M(+7.1%) |
| Sept 2017 | - | -$5.73 M(+4.6%) | -$19.76 M(+6.1%) |
| June 2017 | - | -$5.48 M(+25.9%) | -$18.62 M(+5.6%) |
| Mar 2017 | - | -$4.35 M(+3.4%) | -$17.64 M(-2.1%) |
| Dec 2016 | -$18.02 M(+9.8%) | -$4.21 M(-8.3%) | -$18.03 M(-1.7%) |
| Sept 2016 | - | -$4.59 M(+2.1%) | -$18.33 M(+1.3%) |
| June 2016 | - | -$4.49 M(-5.1%) | -$18.10 M(+3.4%) |
| Mar 2016 | - | -$4.74 M(+5.0%) | -$17.50 M(+6.6%) |
| Dec 2015 | -$16.41 M(+18.3%) | -$4.51 M(+3.5%) | -$16.41 M(+5.0%) |
| Sept 2015 | - | -$4.36 M(+12.0%) | -$15.63 M(+4.3%) |
| June 2015 | - | -$3.89 M(+6.6%) | -$14.98 M(+7.1%) |
| Mar 2015 | - | -$3.65 M(-2.2%) | -$14.00 M(+0.9%) |
| Dec 2014 | -$13.87 M(+74.6%) | -$3.73 M(+0.5%) | -$13.87 M(+13.7%) |
| Sept 2014 | - | -$3.71 M(+27.8%) | -$12.20 M(+12.3%) |
| June 2014 | - | -$2.90 M(-17.7%) | -$10.86 M(+12.0%) |
| Mar 2014 | - | -$3.53 M(+71.3%) | -$9.70 M(+22.1%) |
| Dec 2013 | -$7.94 M(-21.1%) | -$2.06 M(-13.3%) | -$7.94 M(+2.3%) |
| Sept 2013 | - | -$2.37 M(+36.3%) | -$7.77 M(-0.6%) |
| June 2013 | - | -$1.74 M(-1.6%) | -$7.82 M(+28.7%) |
| Mar 2013 | - | -$1.77 M(-6.0%) | -$6.08 M(+41.1%) |
| Dec 2012 | -$10.07 M(-17.9%) | -$1.88 M(-22.3%) | -$4.31 M(+77.7%) |
| Sept 2012 | - | -$2.42 M | -$2.42 M |
| Dec 2011 | -$12.27 M | - | - |
FAQ
- What is Biocept annual earnings before interest & taxes?
- What is the all time high annual EBIT for Biocept?
- What is Biocept annual EBIT year-on-year change?
- What is Biocept quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Biocept?
- What is Biocept quarterly EBIT year-on-year change?
- What is Biocept TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Biocept?
- What is Biocept TTM EBIT year-on-year change?
What is Biocept annual earnings before interest & taxes?
The current annual EBIT of BIOC is -$31.90 M
What is the all time high annual EBIT for Biocept?
Biocept all-time high annual earnings before interest & taxes is -$879.00 K
What is Biocept annual EBIT year-on-year change?
Over the past year, BIOC annual earnings before interest & taxes has changed by -$29.49 M (-1224.03%)
What is Biocept quarterly earnings before interest & taxes?
The current quarterly EBIT of BIOC is -$3.58 M
What is the all time high quarterly EBIT for Biocept?
Biocept all-time high quarterly earnings before interest & taxes is $2.66 M
What is Biocept quarterly EBIT year-on-year change?
Over the past year, BIOC quarterly earnings before interest & taxes has changed by +$6.31 M (+63.79%)
What is Biocept TTM earnings before interest & taxes?
The current TTM EBIT of BIOC is -$30.54 M
What is the all time high TTM EBIT for Biocept?
Biocept all-time high TTM earnings before interest & taxes is $2.33 M
What is Biocept TTM EBIT year-on-year change?
Over the past year, BIOC TTM earnings before interest & taxes has changed by -$15.17 M (-98.76%)